baber/WOPTO huggingface dataset:
Patent AU-2119592-A (AU)
Title: Process for obtaining purified aqueous hydrogen peroxide solutions
IPC: C01B15/013
Filed: 1992-08-21
Abstract: Process for obtaining purified hydrogen peroxide solutions, consisting in evaporating the crude aqueous hydrogen peroxide solution containing the impurities and feeding by means of the vapour phase produced the foot of a distillation column provided in its lower part with a zone for washing the vapour phase with a small flow of liquid which refluxes in the bottom of the column and which has the same composition as the purified aqueous hydrogen peroxide solution forming the product leaving the column, in drawing off this purified product at a column height such that the draw-off is carried out above the vapour phase washing zone and in collecting at the bottom of the column a residue consisting of the small flow of washing liquid which contains most of the impurities. The washing zone has a diameter which is greater than that of the remainder of the column. Distillation column for carrying out the process.
Patent AU-2128892-A (AU)
Title: N-substituted aminomethanediphosphonic acids
IPC: A61P3/00
Filed: 1992-08-25
Abstract: N-substituted aminomethanediphosphonic acids of the formula I, <CHEM> wherein R1, X, alk1, R2 and n are as defined in the description, and salts thereof, have valuable pharmaceutical properties and are effective e.g. in the treatment of conditions which can be associated with disorders of the calcium metabolism. They are manufactured in a manner known per se.
Patent AU-2176195-A (AU)
Title: Leucite-containing phosposilicate glass-ceramic
Inventor: FRANK MARTIN
IPC: C03C10/00
Filed: 1995-06-19
Abstract: A phosphosilicate glass-ceramic has a leucite crystal phase, at least one other crystal phase, and one or more glass phases, and contains 49.0-57.5 wt.% SiO2, 11.4-21.0% Al2O3, 0.5-5.5% P2O5, 2.5-11.5% CaO, 9.0-22.5% K2O, 1.0-9.5% Na2O, 0-2.5% Li2O, 0-2.0% B2O3, 0-3.0% TiO2, 0.8-8.5% ZrO2, 0-3.0% CeO2, 0.25-2.5% F, 0-3.0% La2O3, 0-3.0% ZnO, 0-3.0% BaO, 0-3.0% MgO and 0-3.0% SrO.
Patent AU-2340588-A (AU)
Title: Apparatus for mounting and dismounting of tyres
IPC: B60C25/132
Filed: 1988-10-04
Abstract: An apparatus for mounting and dismounting of tyres based on a principle where a wedge-shaped tyre lever is forced in between rim and bead wire in order to force the bead wire inside or outside the rim by a relative movement along the edge of the rim. The apparatus according to the invention has a double set of tyre levers (5) which by the use of associated rim squeeze devices (6,7) can advance stepwise along the rim edge (K) by alternate activation of the rim clamps, the distance between the two tyre levers being increased and reduced forcibly at the same time. In this way, the tyre levers can be made to work on the entire wheel circumference. The apparatus is operated by compressed air. A manually operated directional valve controls the working rate. The apparatus is mobile and can be carried and operated by a single person and requires no adjustment.
Patent AU-2411000-A (AU)
Title: Sharps container
Inventor: VOJTASEK WILLIAM J
IPC: A61M5/158
Filed: 2000-01-11
Abstract: A sharps cup for receiving and storing a plurality of needles against accidental dislodgement, includes a plastic cup defining a bottom, a top, a sidewall connecting the bottom and the top, and a vertically extending central post disposed within and horizontally spaced from the sidewall. A resilient disc is disposed within the cup and defines a plurality of slots and segments, the segments being intermediate the slots, and each segment having a free end spaced from the post. A plastic cover for the cup defines a plurality of needle-receiving passageways therethrough adjacent the post and communicating with spaces between the post and the segment free ends. Each segment free end is individually deflectable toward the bottom adjacent the post by insertion of a needle downwardly through one of the passageways and then into the space intermediate the post and the segment free end. The disc is of a harder material than the needle so that the segment resists withdrawal of the needle by biting into the needle as the segment free end attempts to return from its deflected orientation during withdrawal of the needle.
Patent AU-2540992-A (AU)
Title: Friction rock anchor
IPC: E21D21/00
Filed: 1992-08-25
Abstract: An open seam friction rock stabilizer having a compressible body with portions alternately in contact with and not in contact with borehole wall, the contacting portions being separated by an angle between 70 degrees and 150 degrees.
Patent AU-2621995-A (AU)
Title: Indole derivatives as prodrugs of 5-ht1-like receptor agonists
Inventor: BLADE ROBERT JOHN
IPC: A61K31/422
Filed: 1995-05-31
Abstract: PCT No. PCT/GB95/01249 Sec. 371 Date May 23, 1997 Sec. 102(e) Date May 23, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32966 PCT Pub. Date Dec. 7, 1995A compound of formula (I), wherein A is C1-6alkyl, -O-C1-6alkyl, -O-phenyl or phenyl, optionally substituted by C1-3alkyl or halogen; n is an integer of from 0 to 3; W is a group of formula (i), (ii) or (iii) where R is hydrogen or C1-4alkyl, x is -O-, -S-, -NH-, or -CH2-, Y is oxygen or sulphur and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; and Z is a group of formula (iv) -HC2CH2NR1R2(v) or (vi) where R1 and R2 are independently selected from hydrogen and C1-4alkyl and R3 is hydrogen or C1-4alkyl; and salts, solvates and physiologically functional derivatives thereof.
Patent AU-2981995-A (AU)
Title: Sulfonamide derivatives of azolones anti-helicobacter agents
Inventor: HEERES JAN
IPC: C07D233/70
Filed: 1995-07-05
Abstract: The invention is concerned with the compounds having the formula    <IMAGE>  (I)  the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Y is CH or N; R1, R2 and R3 each independently are hydrogen or C1-4alkyl; R4 and R5 each independently are hydrogen, halo, C1-4alkyl, C1-4alkyloxy, hydroxy, trifluoromethyl, trifluoromethyloxy or difluoromethyloxy; R6 is C1-4alkyl; or phenyl optionally substituted with halo, C1-4alkylcarbonylamino, C1-4alkyloxy, C1-4alkyl or nitro; Z is C=O or CHOH; and   <IMAGE>   is a radical of formula    <IMAGE>  (a-1)   <IMAGE>  (a-2)   <IMAGE>  (a-3)   <IMAGE>  (a-4)   <IMAGE>  (a-5)   <IMAGE>  (a-6)  or   <IMAGE>  (a-7)  Compositions comprising said compounds, processes for preparing the same and the use of these compounds as a method of treating Helicobacter infection.
Patent AU-3035189-A (AU)
Title: Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
Inventor: STEIN MICHAEL
IPC: A61K49/22
Filed: 1989-02-01
Abstract: The invention relates to gas- or liquid-containing microparticles based on amyloses, process for producing them and their use as diagnostic agents.
Patent AU-3184101-A (AU)
Title: Device for injecting a dose of liquid, in particular medicinal liquid
Inventor: LOURENCO ARMINDO
IPC: A61M5/50
Filed: 2001-01-05
Abstract: An injection device includes a syringe body tubular element ( 9 ) provided with finger-pressing members ( 23 ) for holding the injection device to inject a dose of liquid, in particular medicinal liquid. The finger-pressing members consist of a flange ( 23 ), provided with an upper surface and a lower surface, including two portions with symmetrical outline ( 50, 51 ), called gripping portions, having lower support surfaces for the user's fingers, and between the support surfaces, two portions with diametrically opposed symmetrical outlines ( 52 ), called indexing portions, including in the extension of the lower surface of the flange, a lower surfaces having a convex profile formed by two slopes symmetrical relative to a longitudinal axis.
Patent AU-3207995-A (AU)
Title: Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines
Inventor: MOSCHEL ROBERT C
IPC: C07D239/46
Filed: 1995-07-31
Abstract: The present invention provides AGT inactivating compounds such as 7- or 9-substituted 8- aza- O<6>-benzylguanines of formula (III) or (IV), and related substituted O<6>-benzyl guanines, as well as pharmaceutical compositions comprising such compounds along with a pharmaceutically acceptable carrier. The present invention further provides a method of enhancing the chemotherapeutic treatment of tumour cells in a mammal with an antineoplastic alkylating agent which causes cytotoxic lesions at the O<6>- position of guanine, by administering to a mammal an effective amount of one of the aforesaid compounds, 2,4-diamino-6-benzyloxy-s-triazine, or 8-aza-O<6>-benzylguanine, and administering to the mammal an effective amount of an antineoplastic alkylating agent which causes cytotoxic lesions at the O<6>- position of guanine. <CHEM> <CHEM>
Patent AU-3215995-A (AU)
Title: Titanium engine valve
Inventor: JETTE PAUL M
IPC: F01L3/02
Filed: 1995-08-09
Abstract: A titanium engine valve is fabricated with discrete head and stem portions, preferably joined by inertia welding and/or diffusion bonding. The joint between the head and stem portions is located well up on the valve stem so that it is not exposed below the valve guide. The head portion, including a fillet region and lower stem region, is composed of a first material comprising titanium, such as a conventional high strength titanium alloy. Alternatively, the head portion may consist of a cast or forged heat treated TIC. The stem portion, which is not directly exposed to the hostile environment of the combustion chamber, is composed of a second material comprising titanium, such as mill annealed titanium alloy rod stock. The resulting valve is, therefore, much less expensive to manufacture than a conventional titanium valve without sacrificing any mechanical characteristics in the portions of the valve subjected to high stress and temperature.
Patent AU-3282899-A (AU)
Title: Steel material for hot work tools
Inventor: SANDBERG ODD
IPC: C22C38/00
Filed: 1999-02-18
Abstract: A steel material for hot work tools has an alloy composition that in weight-% essentially consists of: 0.3-0.4 C, 0.2-0.8 Mn, 4-6 Cr, 1.8-3 Mo, 0.4-0.8 V, balance iron and unavoidable metallic and non-metallic impurities, said non-metallic impurities comprising silicon, nitrogen, oxygen, phosphor and sulfur, the contents of which does not exceed the following maximum contents: max. 0.25 Si, max. 0.010 N, max. 10 ppm O, max. 0.010 weight-% P.
Patent AU-3479193-A (AU)
Title: Method and apparatus for charging, thawing, and formatting a battery
Inventor: PODRAZHANSKY YURY
IPC: H01M10/48
Filed: 1993-01-19
Abstract: A method and an apparatus for rapidly charging a battery. The preferred charging method comprises applying one or more charging pulses (C1, C2), separated by a waiting period (CW1), with the last charging pulse, if there are more than one, being followed by a second waiting period (CW2). This is then followed by a series of discharging pulses (D1, D2, D3), which are separated by waiting periods (DW1, DW2), and followed by a last waiting period (DW3) before the occurrence of the next charging pulse (C1). The discharging pulses preferably have a magnitude which is approximately the same as the magnitude of the charging pulses but which have a duration which is substantially smaller than the duration of the charging pulses. The discharging pulses serve to create and disperse ions throughout the electrolyte of the battery so that the ions do not shield the plates of the battery from further charge transfer. Multiple discharge pulses are used rather than a single discharging pulse so that natural chemical and electrical gradients within the battery will serve to disperse the ions more evenly throughout the electrolyte. The use of discharging pulses of an extremely small duration does not cause any significant discharge of the battery but does increase the rate at which the battery can be charged and the efficiency with which the battery can be charged, thereby minimizing charging time and battery heating. Also disclosed are a method and an apparatus for thawing and charging a frozen battery, for formatting a new battery, for determining the state of formation of a battery, and for determining the state of charge of a battery.
Patent AU-3630593-A (AU)
Title: Fuel injection device working according to the solid energy accumulator principal, for internal combustion engines
Inventor: HEIMBERG WOLFGANG
IPC: F02N19/00
Filed: 1993-03-04
Abstract: The fuel injection system has a unit for producing increase in pressure which includes an impingement device (25), e.g. a rear wall or a piston type stop. The impingement device is provided in a fuel storage element (6) arranged outside an injection pump (1), connected at a pressure line (2) between the injection pump and the injection nozzle (3). The storage element (6) includes a fuel storage chamber (22), in which a spring preloaded diaphragm (23) is arranged. One side of the chamber is arranged at a specified distance to the diaphragm.
Patent AU-3846593-A (AU)
Title: Ball valve with offset through-duct
Inventor: BONETTI GIULIO
IPC: F16K5/06
Filed: 1993-05-07
Abstract: A fluid ducting valve of the type comprising an interception ball (8) fitted with a through-duct (9) and sealing rings (14,15) interposed between such ball and fluid flow ducts (2',3'), in which such through-duct (9) of ball (8) is located with its longitudinal axis offset in the downstream direction relative to the axis of rotation of ball (8), when the latter is rotated to the position of interception, the relative distance between the longitudinal axis of duct (9) and the axis of rotation of ball (8) being such that upstream apertures (9a) of duct (9) are always closed before downstream apertures (9b) move on downstream sealing rings (15) with the valve either closed or open. <IMAGE>
Patent AU-3888797-A (AU)
Title: Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
Inventor: GAST MICHAEL JAY
IPC: A61K31/565
Filed: 1997-07-23
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for a combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, and wherein the same dosage of the progestin and estrogen combination is administered in each of the 23-25 days.
Patent AU-3905585-A (AU)
Title: Vinyl amide and acrylic ester copolymer for contact lens
Inventor: LIM DRAHOSLAV
IPC: C08F226/10
Filed: 1985-02-19
Abstract: An interpenetrating network polymer comprising of (a) hydrophilic vinyl amide, (b) (5-alkylene-m-dioxanyl) acrylic ester, (c) a first crosslinking agent having an affinity for vinyl amide, and (d) a second crosslinking agent having an affinity for acrylic ester.
Patent AU-4141685-A (AU)
Title: Bell
Inventor: OBORZIL EDIT
IPC: G10K1/071
Filed: 1985-04-18
Abstract: A bell having a mantle which is fully broken through by a plurality of gaps longitudinally and axially formed along the circumference of the mantle and dimensioned to tune the bell to a predetermined tonal frequency range.
Patent AU-4332400-A (AU)
Title: Apparatus and method for kinetic analysis of the intraoperative assay for parathyroid hormone
Inventor: REMALEY ALAN T
IPC: G16H50/30
Filed: 2000-04-07
Abstract: An apparatus for predicting a residual hormone concentration in a patient after a removal of a portion of the patient's glandular tissue which secretes the hormone, includes an input device constructed to receive a plurality of measured hormone concentrations corresponding to a plurality of human fluid samples taken from a patient at a plurality of sample times, respectively; and further includes a computer processor configured to iteratively calculate a residual hormone concentration. In accordance with one feature of the present invention, the computer processor is configured to generate data denoting a residual amount of glandular tissue that will remain in the patient after the removal of the portion of the patient's glandular tissue; and the apparatus further comprises an output device constructed to output the generated data denoting the residual amount of glandular tissue. The computer processor is further configured to iteratively calculate a half-life value of the hormone concentration in the patient.
Patent AU-4383796-A (AU)
Title: Gear-changing mechanism for a bicycle
Inventor: WENDLER JOCHEN
IPC: B62M25/08
Filed: 1995-12-22
Abstract: A gear shift apparatus for bicycles of the kind conventionally known as a derailleur is provided with a selectively actuable master cylinder operatively connected to a slave cylinder. The slave cylinder is mounted in a four-bar-linkage connected to a drive chain guide sprocket such that forces acting transversely of the slave cylinder are substantially avoided.
Patent AU-4389197-A (AU)
Title: Method and system for ensuring the security of service supplies broadcast on a computer network of the internet type
Inventor: ROSSET FRANCK
IPC: H04M1/275
Filed: 1997-09-25
Abstract: The invention concerns a method and a system enabling users ( 11 ) of an Internet type computer network provided with multimedia terminals ( 16 ) comprising a microphone ( 17 ) and connected to an Internet type computer network ( 15 ), remotely located from a service supplier ( 12 ), to accede rapidly and safely, to services ( 30 ) offered by this service supplier ( 12 ). The method comprises the following steps: the service supplier ( 12 ) provides each of the users ( 11 ) of an Internet type computer network ( 15 ) who have subscribed to his services ( 30 ), a card, formatted like a credit card; said card ( 10 ), formatted like a credit card, emits brief identifying sound signals ( 20 ), of the DTMF type, at least partly encrypted, varying with each operation, when it is actuated ( 14 ) by the user ( 11 ); said identifying sound signals are received by the microphone ( 17 ) of the multimedia terminal ( 16 ) and transmitted via the Internet type computer network ( 15 ) to the computer service ( 18 ) of the service supplier; the transmitted signals and the identification data of the subscriber and the card in the possession ( 23 ) of the computer service ( 18 ) are electronically processed ( 24 ) and compared ( 25 ) by the computer service. In the event of coincidence, the subscriber is immediately put through to the services ( 30 ) of the service supplier ( 12 ).
Patent AU-4399999-A (AU)
Title: Stabilisation of pigments and polyunsaturated oils
Inventor: BREIVIK HARALD
IPC: A23K1/18
Filed: 1999-06-25
Abstract: The present invention relates to a method for stabilizing vegetable and animal oils as well as pigments like astaxanthin and canthaxanthin with regard to oxidation. It also relates to a feed for salmonids, and a method for optimising the effect of the pigment in feed for salmonids. Essential feature by the invention are treatment by or presence of urea.
Patent AU-4578996-A (AU)
Title: Improved flexible strip cable
Inventor: LEWIS DAVID EARL
IPC: H01R12/08
Filed: 1996-02-29
Abstract: A flexible strip test cable having an elongated flexible strip cable, a series of strip traces disposed lengthwise on the flexible strip cable and having electrical strip contacts near one end of the flexible strip cable, an extension cable integral with the flexible strip cable and having a width at one end greater than the width of the flexible strip cable, and a series of test traces on the extension cable having electrical test contacts near the end of the extension cable remote from the flexible strip cable. Each of the test traces is electrically connected to one of the strip traces, and the minimum distance between two test contacts is greater than the minimum distance between two strip contacts. The flexible strip test cable may have a tooling guide for aligning a cutting tool with the end of the flexible strip cable which is connected to the extension cable. Alternatively, the test contacts may be electrically accessible through one surface of the extension cable in any pattern so that the minimum distance between two test contacts is greater than the minimum distance between two strip contacts. In still another embodiment, at least one test contact is electrically accessible through one surface of the extension cable and at least one test contact is electrically accessible through the opposing surface of the extension cable. <IMAGE>
Patent AU-4588289-A (AU)
Title: Cloning and expression of simian transforming growth factor-beta 1
IPC: C12N15/12
Filed: 1989-12-04
Abstract: Recombinant transforming growth factor- beta 1 (TGF- beta 1) is expressed to high levels in Chinese hamster ovary (CHO) cells using dihydrofolate reductase (dhfr) gene amplification. The expression plasmid was derived from the pSV2 vectors and contained, in tandem, the simian TGF- beta 1 and mouse dhfr cDNAs. Transcription of both cDNAs was controlled by the SV40 early promoter. Stepwise selection of transfected CHO cells in increasing concentrations of methotrexate yielded cell lines expressing amplified TGF- beta 1 nucleic acid sequences. The expression plasmid DNA was amplified greater than 35-fold in one of the methotrexate selected transfectants. The major proteins secreted by these cells consisted of latent TGF- beta 1 and TGF- beta 1 precursor polypeptides as judged by immunoblots using site-specific anti-peptide antibodies derived from various regions of the TGF- beta 1 precursor. Levels of recombinant TGF- beta 1 protein secreted by these cells approached 30 ug/24 hour/10<7> cells. Expression vectors encoding TGF- beta 1 precursor variants which direct the synthesis and secretion of TGF- beta 1 in transfected mammalian cells are also described.
Patent AU-4655499-A (AU)
Title: High efficiency retroviral vectors that contain none of viral coding sequences
Inventor: KIM SUN-YOUNG
IPC: C12N15/09
Filed: 1999-06-24
Abstract: The present invention relates to improved retroviral vectors for gene therapy. In this invention, retroviral vectors with higher safety and efficiency are constructed from MLV-based starting vectors, MON and MIN. The improved vectors have the following features: 1) sequences corresponding to MLV-derived pol gene are completely deleted in the vectors, avoiding homologous recombination which has been a baffling problem in conventional retroviral vectors, 2) a heterologous intron, splicing acceptor and/or non-coding sequence are/is inserted into the upstream position of a cloning site, maximizing the expression of a foreign gene through efficient splicing, 3) the vectors contain either the full-length U3 sequence of 5' LTR or a strong heterologous promoter instead, permitting the abundant production of RNA, 4) either IRES (Internal Ribosomal Entry Site) or internal SV40 minimal promoter is inserted into the downstream position of cloning site, enabling the simultaneous expression of two or more foreign genes. Since the improved retroviral vectors of this invention turn out to be safe and to express the foreign gene efficiently, they are useful for gene therapy and the like.
Patent AU-4684500-A (AU)
Title: Method and apparatus for adjustable sling for treatment of urinary stress incontinence
Inventor: COOK TIMOTHY C
IPC: A61F2/00
Filed: 2000-04-28
Abstract: One embodiment of the present subject matter includes an implantable, adjustable sling for a body which includes an implantable sling cup connected to a first strap and a second strap, the first strap and the second strap adapted to be anchored within the body and at least one adjustable element forming an integral portion of the first strap.